NVO logo

NVO
Novo Nordisk A/S

30,994
Mkt Cap
$137.49B
Volume
19.48M
52W High
$81.44
52W Low
$35.12
PE Ratio
11.75
NVO Fundamentals
Price
$40.81
Prev Close
$39.32
Open
$39.79
50D MA
$40.49
Beta
0.91
Avg. Volume
19.26M
EPS (Annual)
$3.49
P/B
5.94
Rev/Employee
$679,358.45
$242,651.58
Loading...
Loading...
News
all
press releases
Novo Nordisk A/S (NYSE:NVO) Shares Up 3.8% - Still a Buy?
Novo Nordisk A/S (NYSE:NVO) Shares Up 3.8% - Here's What Happened...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Top Research Reports for Netflix, PepsiCo & Novo Nordisk
Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), PepsiCo, Inc. (PEP) and Novo Nordisk A/S (NVO), as well as two micro-cap stocks, Hawthorn Bancshares, Inc. (HWBK) and Park Aerospace Corp. (PKE).
Zacks·8h ago
News Placeholder
The $1 Trillion Race: Why Eli Lilly Is Leaving Novo Nordisk in the Dust
Key PointsEli Lilly has a stronger weight-loss portfolio than Novo Nordisk...
Nasdaq News: Markets·11h ago
News Placeholder
Best Pharmaceutical Stocks To Watch Now - April 15th
Eli Lilly and Company, AbbVie, Novo Nordisk A/S, Abbott Laboratories, Pfizer, Vertex Pharmaceuticals, and Astrazeneca are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...
MarketBeat·12h ago
News Placeholder
Company News for Apr 15, 2026
Companies In The News Are: JNJ, WFC, ACI, NVO.
Zacks·15h ago
News Placeholder
NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up
Novo Nordisk stock up as it teams up with OpenAI to deploy AI across drug discovery and operations, aiming to speed therapies, boost efficiency and counter rising competition.
Zacks·15h ago
News Placeholder
Freestone Capital Holdings LLC Sells 32,133 Shares of Novo Nordisk A/S $NVO
Freestone Capital Holdings LLC reduced its holdings in shares of Novo Nordisk A/S (NYSE:NVO - Free Report) by 56.3% in the 4th quarter, according to its most recent filing with the Securities...
MarketBeat·21h ago
News Placeholder
Novo Nordisk partners with OpenAI to speed drug discovery
The race to develop the next generation of medicines just got faster. At least, that is the bet Novo Nordisk is making.The Danish pharmaceutical company announced a strategic partnership with OpenAI...
TheStreet.com·23h ago
News Placeholder
Novo Nordisk A/S (NYSE:NVO) Trading Up 3.6% - Time to Buy?
Novo Nordisk A/S (NYSE:NVO) Shares Up 3.6% - Still a Buy...
MarketBeat·1d ago
News Placeholder
Novo Nordisk CEO: This is where science meets speed and scale
Maziar Mike Doustdar, CEO of Novo Nordisk, says AI partnership with OpenAI will speed drug discovery and delivery, boost accuracy and strengthen confidence in Wegovy despite rising competition...
CNBC Television-YouTube·1d ago
<
1
2
...
>

Latest NVO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.